BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

884 related articles for article (PubMed ID: 10588410)

  • 1. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.
    Hobart MP; Goldberg R; Bartko JJ; Gold JM
    Am J Psychiatry; 1999 Dec; 156(12):1951-7. PubMed ID: 10588410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity.
    Gold JM; Queern C; Iannone VN; Buchanan RW
    Am J Psychiatry; 1999 Dec; 156(12):1944-50. PubMed ID: 10588409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia.
    Wilk CM; Gold JM; Bartko JJ; Dickerson F; Fenton WS; Knable M; Randolph C; Buchanan RW
    Am J Psychiatry; 2002 May; 159(5):838-44. PubMed ID: 11986139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative psychometric properties of the BACS and RBANS in patients with schizophrenia and schizoaffective disorder.
    Chianetta JM; Lefebvre M; LeBlanc R; Grignon S
    Schizophr Res; 2008 Oct; 105(1-3):86-94. PubMed ID: 18790606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief cognitive assessment in schizophrenia: normative data for the Repeatable Battery for the Assessment of Neuropsychological Status.
    Wilk CM; Gold JM; Humber K; Dickerson F; Fenton WS; Buchanan RW
    Schizophr Res; 2004 Oct; 70(2-3):175-86. PubMed ID: 15329294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results.
    Dittmann S; Seemüller F; Schwarz MJ; Kleindienst N; Stampfer R; Zach J; Born C; Bernhard B; Fast K; Grunze H; Engel RR; Severus E
    Bipolar Disord; 2007; 9(1-2):63-70. PubMed ID: 17391351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RBANS neuropsychological profiles within schizophrenia samples recruited from non-clinical settings.
    Loughland CM; Lewin TJ; Carr VJ; Sheedy J; Harris AW
    Schizophr Res; 2007 Jan; 89(1-3):232-42. PubMed ID: 17049816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of cognitive impairment with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in adolescents with psychotic symptomatology.
    Holzer L; Chinet L; Jaugey L; Plancherel B; Sofia C; Halfon O; Randolph C
    Schizophr Res; 2007 Sep; 95(1-3):48-53. PubMed ID: 17629676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) to investigate group and gender differences in schizophrenia and bipolar disorder.
    Gogos A; Joshua N; Rossell SL
    Aust N Z J Psychiatry; 2010 Mar; 44(3):220-9. PubMed ID: 20050718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the Repeatable Battery for the Assessment of Neuropsychological Status.
    Dickerson F; Boronow JJ; Stallings C; Origoni AE; Cole SK; Yolken RH
    Psychiatry Res; 2004 Nov; 129(1):45-53. PubMed ID: 15572184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of Cognitive Impairment in Schizophrenia: Reliability, Sensitivity, and Specificity of the Repeatable Battery for the Assessment of Neuropsychological Status in a Spanish Sample.
    De la Torre GG; Perez MJ; Ramallo MA; Randolph C; González-Villegas MB
    Assessment; 2016 Apr; 23(2):221-31. PubMed ID: 25934161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and neuropsychological correlates of insight in schizophrenia and bipolar I disorder: does diagnosis matter?
    Varga M; Magnusson A; Flekkøy K; David AS; Opjordsmoen S
    Compr Psychiatry; 2007; 48(6):583-91. PubMed ID: 17954145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of neuropsychological effort test performance in schizophrenia.
    Morra LF; Gold JM; Sullivan SK; Strauss GP
    Schizophr Res; 2015 Mar; 162(1-3):205-10. PubMed ID: 25583248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Battery for assessment of neuropsychological status (RBANS) in schizophrenia: a pilot study in the Spanish population.
    Sanz JC; Vargas ML; Marín JJ
    Acta Neuropsychiatr; 2009 Feb; 21(1):18-25. PubMed ID: 25384525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.
    Bilder RM; Goldman RS; Robinson D; Reiter G; Bell L; Bates JA; Pappadopulos E; Willson DF; Alvir JM; Woerner MG; Geisler S; Kane JM; Lieberman JA
    Am J Psychiatry; 2000 Apr; 157(4):549-59. PubMed ID: 10739413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: a comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP).
    Cuesta MJ; Pino O; Guilera G; Rojo JE; Gómez-Benito J; Purdon SE; Franco M; Martínez-Arán A; Segarra N; Tabarés-Seisdedos R; Vieta E; Bernardo M; Crespo-Facorro B; Mesa F; Rejas J
    Schizophr Res; 2011 Aug; 130(1-3):137-42. PubMed ID: 21652178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct contribution of working memory and social comprehension failures in neuropsychological impairment in schizophrenia.
    Nestor PG; Niznikiewicz M; McCarley RW
    J Nerv Ment Dis; 2010 Mar; 198(3):206-12. PubMed ID: 20215998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and cognitive factors affecting psychosocial functioning in remitted patients with bipolar disorder.
    Konstantakopoulos G; Ioannidi N; Typaldou M; Sakkas D; Oulis P
    Psychiatriki; 2016; 27(3):182-191. PubMed ID: 27837572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery.
    Goldberg TE; Gold JM; Greenberg R; Griffin S; Schulz SC; Pickar D; Kleinman JE; Weinberger DR
    Am J Psychiatry; 1993 Sep; 150(9):1355-62. PubMed ID: 8352346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.